SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
Portfolio Pulse from
New research presented at SABCS 2024 highlights iCAD's AI-based imaging technology, which reveals a higher prevalence of Breast Arterial Calcifications (BAC) in breast cancer patients. This suggests a potential need for cardiovascular assessments alongside oncological treatments.
December 11, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
iCAD's AI-based imaging technology shows higher BAC prevalence in breast cancer patients, indicating a potential new market for cardiovascular assessments in oncology.
The research highlights iCAD's technology's effectiveness in identifying BAC, which could lead to increased demand for their imaging solutions in both oncology and cardiology sectors. This could positively impact iCAD's market position and revenue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90